The sentence: “Patients eligible to enter MANET were established on 2 NRTIs plus a PI/b for ≥12 months and showed a CD4 count >200 cells/mm3 and a plasma HIV-1 RNA load.” should read: “Patients eligible to enter MANET were established on 2 NRTIs plus a PI/b for ≥12 weeks and showed a CD4 count >100 cells/mm3 and a plasma HIV-1 RNA load.” This has been updated in the original article.
. 2019 Apr 3;6(4):ofz142. doi: 10.1093/ofid/ofz142
Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
Adam Abdullahi
, Olga Mafotsing Fopoussi
, Judith Torimiro
, Mark Atkins
, Charles Kouanfack
, Anna Maria Geretti
Adam Abdullahi
Find articles by Adam Abdullahi
Olga Mafotsing Fopoussi
Find articles by Olga Mafotsing Fopoussi
Judith Torimiro
Find articles by Judith Torimiro
Mark Atkins
Find articles by Mark Atkins
Charles Kouanfack
Find articles by Charles Kouanfack
Anna Maria Geretti
Find articles by Anna Maria Geretti
Collection date 2019 Apr.
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC6446136 PMID: 30968060
This corrects the article "Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting" in volume 5, ofy251.